Understanding Natural Protection Against Cognitive Decline: The 100-plus Study
Principal Investigator
Henne Holstege, PhD
Alzheimer Center of the VU University Medical Center
Amsterdam, Netherlands
About the Research Project
Program
Award Type
Other
Award Amount
$100,000
Active Dates
August 01, 2026 - July 31, 2027
Grant ID
CA2027001
Goals
Maintaining the infrastructure of the 100-plus Study: cohort expansion and biomaterial collection
Unique and Innovative
These activities preserve the core infrastructure required to study why some individuals maintain cognitive health into extreme old age. This provides the foundation for the scientific phase of the 100-plus Study in which donated brains can ultimately be linked to the longitudinal cognitive, clinical, genetic and biomarker information collected from participants during life.
Foreseeable Benefits
1. Maintain nationwide recruitment and longitudinal follow-up.
Maintain the trained personnel and participant coordination required for nationwide recruitment and uninterrupted longitudinal follow-up throughout the funding period. Eligible and willing participants will continue to be offered home-based cognitive assessments and biosample collection.
2. Maintain and expand the brain-donation programme.
Maintain active recruitment of prospective brain donors and the coordination, technical support, sample processing and biobanking infrastructure required for the brain-donation programme. We aim to continue the current trajectory towards approximately 50 additional completed brain donations over the two-year Fidelity funding period. Each new donation will be processed, neuropathologically assessed, biobanked and linked to the participant’s longitudinal cognitive, clinical, genetic and biomarker data.
Related Grants
BrightFocus Foundation
A New Role for Amyloid Precursor Protein as a Mechanical Linker in Neurons
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Ben Goult, PhD
Current Organization
University of Liverpool
A New Role for Amyloid Precursor Protein as a Mechanical Linker in Neurons
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Ben Goult, PhD
Current Organization
University of Liverpool
BrightFocus Foundation
How Biology and Blood Markers Shape Alzheimer’s Risk in Diverse Communities
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
María Carolina Dalmasso, PhD
Current Organization
Studies in Neuroscience and Complex Systems Unit
How Biology and Blood Markers Shape Alzheimer’s Risk in Diverse Communities
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
María Carolina Dalmasso, PhD
Current Organization
Studies in Neuroscience and Complex Systems Unit
BrightFocus Foundation
Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2027
Principal Investigator
Yuanyuan Wei, PhD
Current Organization
David Geffen School of Medicine at UCLA
Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2027
Principal Investigator
Yuanyuan Wei, PhD
Current Organization
David Geffen School of Medicine at UCLA